4.3 Article

Mathematical modeling in cancer nanomedicine: a review

期刊

BIOMEDICAL MICRODEVICES
卷 21, 期 2, 页码 -

出版社

SPRINGER
DOI: 10.1007/s10544-019-0380-2

关键词

Agent-based modeling; Cancer treatment; Drug transport; Mechanistic modeling; Multiscale; Pharmacokinetics and pharmacodynamics

资金

  1. National Science Foundation [DMS-1716737]
  2. National Institutes of Health (NIH) [1U01CA196403, 1U01CA213759, 1R01CA226537, 1R01CA222007, U54CA210181]
  3. University of Texas System STARS Award
  4. Sandia National Laboratories LDRD program
  5. U.S. Department of Energy's National Nuclear Security Administration [DE-NA0003525]

向作者/读者索取更多资源

Cancer continues to be among the leading healthcare problems worldwide, and efforts continue not just to find better drugs, but also better drug delivery methods. The need for delivering cytotoxic agents selectively to cancerous cells, for improved safety and efficacy, has triggered the application of nanotechnology in medicine. This effort has provided drug delivery systems that can potentially revolutionize cancer treatment. Nanocarriers, due to their capacity for targeted drug delivery, can shift the balance of cytotoxicity from healthy to cancerous cells. The field of cancer nanomedicine has made significant progress, but challenges remain that impede its clinical translation. Several biophysical barriers to the transport of nanocarriers to the tumor exist, and a much deeper understanding of nano-bio interactions is necessary to change the status quo. Mathematical modeling has been instrumental in improving our understanding of the physicochemical and physiological underpinnings of nanomaterial behavior in biological systems. Here, we present a comprehensive review of literature on mathematical modeling works that have been and are being employed towards a better understanding of nano-bio interactions for improved tumor delivery efficacy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据